106 related articles for article (PubMed ID: 25199965)
1. Time-related changes in determinants of antiplatelet effect of clopidogrel in patients after myocardial infarction.
Kubica A; Kasprzak M; Siller-Matula J; Koziński M; Pio Navarese E; Obońska K; Andruszkiewicz A; Sztuba B; Fabiszak T; Swiątkiewicz I; Paciorek P; Kubica J
Eur J Pharmacol; 2014 Nov; 742():47-54. PubMed ID: 25199965
[TBL] [Abstract][Full Text] [Related]
2. The impact of smoking on the antiplatelet action of clopidogrel in non-ST-elevation myocardial infarction patients: results from the ISAR-REACT 4 platelet substudy.
Sibbing D; Bernlochner I; Schulz S; Massberg S; Schömig A; Mehilli J; Kastrati A
J Thromb Haemost; 2012 Oct; 10(10):2199-202. PubMed ID: 22845802
[No Abstract] [Full Text] [Related]
3. Early Medication Nonadherence After Acute Myocardial Infarction: Insights into Actionable Opportunities From the TReatment with ADP receptor iNhibitorS: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) Study.
Mathews R; Peterson ED; Honeycutt E; Chin CT; Effron MB; Zettler M; Fonarow GC; Henry TD; Wang TY
Circ Cardiovasc Qual Outcomes; 2015 Jul; 8(4):347-56. PubMed ID: 26038524
[TBL] [Abstract][Full Text] [Related]
4. Effects of exercise on platelet reactivity after myocardial infarction: a randomized clinical trial.
Dalçóquio TF; Alves Dos Santos M; Silva Alves L; Bittar Brito Arantes F; Ferreira-Santos L; Pinto Brandão Rondon MU; Furtado RHM; Gehlen Ferrari A; Genestreti Rizzo PR; Salsoso R; Franci A; Moreira Baracioli L; de Nazare Nunes Alves MJ; Negrão CE; Nicolau JC
Platelets; 2023 Dec; 34(1):2139821. PubMed ID: 36377063
[TBL] [Abstract][Full Text] [Related]
5. Serum Free Triiodothyronine and the Responsiveness to Clopidogrel in Patients Undergoing Elective Percutaneous Coronary Intervention.
Ye Y; Zhao X; Zeng Y
Adv Ther; 2021 Jun; 38(6):3077-3088. PubMed ID: 33913121
[TBL] [Abstract][Full Text] [Related]
6. Clopidogrel induced reduction in neutrophil count: An overlooked beneficial effect?
De Servi S; Landi A; Savonitto S
Eur J Intern Med; 2024 Jun; 124():32-34. PubMed ID: 38582734
[TBL] [Abstract][Full Text] [Related]
7. A young patient with recurrent myocardial infarction within a half month.
Chen S; Jiang W; Wang J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 47(6):809-813. PubMed ID: 35837782
[TBL] [Abstract][Full Text] [Related]
8. In-vitro antiplatelet effect of melatonin in healthy individuals and patients with type 2 diabetes mellitus.
Böhm A; Lauko V; Dostalova K; Balanova I; Varga I; Bezak B; Jajcay N; Moravcik R; Lazurova L; Slezak P; Mojto V; Kollarova M; Petrikova K; Danova K; Zeman M
J Endocrinol Invest; 2023 Dec; 46(12):2493-2500. PubMed ID: 37148530
[TBL] [Abstract][Full Text] [Related]
9. Effect of PEAR1 Genetic Variants on 1-Year Outcomes in Chinese Patients with Acute Myocardial Infarction After Percutaneous Coronary Intervention.
Yao Y; Tang XF; He C; Song Y; Xu JJ; Meng XM; Xu B; Gao RL; Yuan JQ
J Atheroscler Thromb; 2018 May; 25(5):454-459. PubMed ID: 29212986
[TBL] [Abstract][Full Text] [Related]
10. Clopidogrel: still king of the ring for elective percutaneous coronary intervention!
Montalescot G; Ferrante A
EuroIntervention; 2023 Mar; 18(15):1213-1214. PubMed ID: 36939107
[No Abstract] [Full Text] [Related]
11. Longer-Duration Dual Antiplatelet Therapy in Medically-Treated Patients after Myocardial Infarction: What is the Strength of the Evidence?
Anderson JL
Am J Cardiol; 2024 Jun; 221():126-127. PubMed ID: 38649127
[No Abstract] [Full Text] [Related]
12. Does clopidogrel affect the efficacy of myocardial perfusion imaging?
Bravo PE; Di Carli MF
J Nucl Cardiol; 2016 Aug; 23(4):780-2. PubMed ID: 26338430
[No Abstract] [Full Text] [Related]
13. Adherence to treatment assessed with the Adherence in Chronic Diseases Scale in patients after myocardial infarction.
Kosobucka A; Michalski P; Pietrzykowski Ł; Kasprzak M; Obońska K; Fabiszak T; Felsmann M; Kubica A
Patient Prefer Adherence; 2018; 12():333-340. PubMed ID: 29551891
[TBL] [Abstract][Full Text] [Related]
14. Clopidogrel Pharmacogenomics: Validation in a Population of South-Asian Ancestry.
Kreutz RP
JACC Adv; 2023 Sep; 2(7):100572. PubMed ID: 38939475
[No Abstract] [Full Text] [Related]
15. Cardiovascular and genetic determinants of platelet high responsiveness - Results from the Gutenberg Health Study.
Baidildinova G; Ten Cate V; Panova-Noeva M; Dahlen B; Gieswinkel A; von Ungern-Sternberg S; Rapp S; Strauch K; Beutel ME; Pfeiffer N; Lackner KJ; Munzel T; Ten Cate H; Wild PS; Jurk K
Blood Adv; 2024 May; ():. PubMed ID: 38776438
[No Abstract] [Full Text] [Related]
16. Prasugrel vs. clopidogrel in acute coronary syndrome patients treated with prasugrel.
Olson WH; Ma YW; Laliberté F; Lefebvre P; Crivera C; Schein JR; Fields LE; Dea K; Germain G; Lynch SM
J Clin Pharm Ther; 2014 Dec; 39(6):663-72. PubMed ID: 25252190
[TBL] [Abstract][Full Text] [Related]
17. Impact of clopidogrel plus aspirin versus aspirin alone on the progression of native coronary artery disease after bypass surgery: analysis from the Clopidogrel After Surgery for Coronary Artery DiseasE (CASCADE) randomized trial.
Une D; Al-Atassi T; Kulik A; Voisine P; Le May M; Ruel M
Circulation; 2014 Sep; 130(11 Suppl 1):S12-8. PubMed ID: 25200049
[TBL] [Abstract][Full Text] [Related]
18. Clopidogrel plus aspirin prevents early neurologic deterioration and improves 6-month outcome in patients with acute large artery atherosclerosis stroke.
Wang C; Yi X; Zhang B; Liao D; Lin J; Chi L
Clin Appl Thromb Hemost; 2015 Jul; 21(5):453-61. PubMed ID: 25248816
[TBL] [Abstract][Full Text] [Related]
19. How to improve the concept of individualised antiplatelet therapy with P2Y12 receptor inhibitors--is an algorithm the answer?
Siller-Matula JM; Trenk D; Schrör K; Gawaz M; Kristensen SD; Storey RF; Huber K;
Thromb Haemost; 2015 Jan; 113(1):37-52. PubMed ID: 25231675
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]